BDXB Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Mai 2023 @ 22:00):

Stats
Tagesvolumen	2.76M
Durchschnittsvolumen	449 584
Marktkapitalisierung	13.69B
EPS	$0.526 ( 2023-09-29 )
Last Dividend	$0.750 ( 2023-02-14 )
Next Dividend	$0 ( N/A )
P/E	7.60
ATR14	$0.267 (0.55%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-16	Goette Roland	Sell	2 233	Common Stock
2024-01-03	Shan David	Sell	44	Common Stock
2017-12-29	Ring Timothy M	Sell	0	Common Stock
2023-01-24	Jones Christopher Ian Montague	Buy	848	Common Stock
2023-12-11	Garrison Michael David	Sell	1 239	Common Stock

INSIDER POWER
62.55
Last 100 transactions
Buy: 250 011 \| Sell: 82 118

Volumen Korrelation

Lang: -0.15 (neutral)

Kurz: -0.69 (moderate negative)

Signal:(30.604) Neutral

Becton, Dickinson and Korrelation

10 Am meisten positiv korreliert
AGQ	0.869
SLV	0.857
SIVR	0.856
PSLV	0.853
SO	0.821
TDI	0.817
AEM	0.805

10 Am meisten negativ korreliert
ZSL	-0.852
NM	-0.84
INSW	-0.831
TEX	-0.821
ASC	-0.818
TNP	-0.817
STAR	-0.801

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Becton, Dickinson and Korrelation - Währung/Rohstoff

-0.28
( neutral )

0.12
( neutral )

0.58
( weak )

-0.26
( neutral )

-0.32
( neutral )

Becton, Dickinson and Finanzdaten

Annual	2023
Umsatz:	$19.37B
Bruttogewinn:	$8.17B (42.17 %)
EPS:	$4.97

FY	2023
Umsatz:	$19.37B
Bruttogewinn:	$8.17B (42.17 %)
EPS:	$4.97

FY	2022
Umsatz:	$18.87B
Bruttogewinn:	$8.48B (44.92 %)
EPS:	$5.93

FY	2021
Umsatz:	$20.25B
Bruttogewinn:	$9.43B (46.56 %)
EPS:	$0

Financial Reports:

No articles found.

Becton, Dickinson and Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.750 (N/A)	$0.750 (N/A)	$0.750 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Becton, Dickinson and Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.40 - good (93.96%) | Divividend Growth Potential Score: 4.17 - Stable (16.67%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.792	2020-08-13
Last Dividend	$0.750	2023-02-14
Next Dividend	$0	N/A
Payout Date	2023-03-01
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$8.29	--
Avg. Dividend % Per Year	2.49%	--
Score	4.64	--
Div. Sustainability Score	9.40
Div.Growth Potential Score	4.17
Div. Directional Score	6.78	--

Next Divdend (Est)
(2024-07-01)

$0.763 Estimate 2.12 %

Dividend Stability

0.17 Bad

Dividend Score

4.64

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2020	$1.542	3.58%
2021	$3.00	5.44%
2022	$3.00	5.65%
2023	$0.750	1.49%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0625	1.500	8.75	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0233	1.200	9.22	10.00	[0 - 0.3]
returnOnEquityTTM	0.0474	1.500	-0.584	-0.876	[0.1 - 1]
payoutRatioTTM	0.910	-1.000	0.903	-0.903	[0 - 1]
currentRatioTTM	1.082	0.800	9.59	7.67	[1 - 3]
quickRatioTTM	0.457	0.800	-2.02	-1.612	[0.8 - 2.5]
cashRatioTTM	0.156	1.500	-0.242	-0.363	[0.2 - 2]
debtRatioTTM	0.308	-1.500	4.86	-7.30	[0 - 0.6]
interestCoverageTTM	8.19	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	11.82	2.00	6.06	10.00	[0 - 30]
freeCashFlowPerShareTTM	9.13	2.00	5.44	10.00	[0 - 20]
debtEquityRatioTTM	0.636	-1.500	7.46	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.414	1.000	6.44	6.44	[0.2 - 0.8]
operatingProfitMarginTTM	0.101	1.000	9.98	9.98	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.213	1.000	9.93	9.93	[0.2 - 2]
assetTurnoverTTM	0.373	0.800	-0.847	-0.678	[0.5 - 2]
Total Score				9.40

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	55.67	1.000	4.48	0	[1 - 100]
returnOnEquityTTM	0.0474	2.50	-0.376	-0.876	[0.1 - 1.5]
freeCashFlowPerShareTTM	9.13	2.00	6.96	10.00	[0 - 30]
dividendYielPercentageTTM	1.592	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	11.82	2.00	6.06	10.00	[0 - 30]
payoutRatioTTM	0.910	1.500	0.903	-0.903	[0 - 1]
pegRatioTTM	0.367	1.500	-0.886	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.176	1.000	8.10	0	[0.1 - 0.5]
Total Score				4.17

Becton, Dickinson and

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.